PLANNING COMMITTEE
Peter Bulova, MD, Associate Professor of General Internal Medicine; Co-Director, Magee Center for Women with Disabilities; Director, University of Pittsburgh Adult Down Syndrome Center; Director, The Department of Medicine Internal Scholars Track
Brian Chicoine, MD, (Conference Director), Medical Director, Advocate Medical Group Adult Down Syndrome Center; Faculty, Lutheran General Hospital Family Medicine Residency
Katie Frank, PhD, OTR/L, Occupational Therapist III, Advocate Medical Group Adult Down Syndrome Center
Amy Lyle, MSSW, Clinic Coordinator, Waisman Down Syndrome Clinic, University of Wisconsin–Madison
Lina Patel, PsyD, Associate Professor of Psychiatry, University of Colorado School of Medicine, Aurora, Colorado
Emilie Perkins, Director of Client and Conference Services, Raybourn Group International
Moya Peterson, PhD, APRN, FNP-BC, Adults with Down Syndrome Specialty Clinic, Department of Family Medicine and Community Health, University of Kansas Medical Center
David Smith, MD
Maria Stanley, MD, FAAP, Annual Symposium Committee Co-Chair; Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic
Mary Stephens, MD, MPH, FAAFP, FAADM, Medical Director, Jefferson Continuing Care Program (JCCP), Associate Professor, Family and Community Medicine
PROGRAM PRESENTERS
Robyn Filipink, MD, Associate Professor of Pediatrics, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
Catherine Franklin, MBBS, FRANZCP, MPhil, Senior Research Fellow and Psychiatrist, Queensland Centre for Intellectual and Developmental Disability, Mater Research Institute, University of Queensland, Brisbane QLD, Australia
Lina Patel, PsyD, Associate Professor of Psychiatry, University of Colorado School of Medicine, Aurora, Colorado
Eileen A. Quinn, MD, Associate Professor of Pediatrics; Division Chief, Developmental and Behavioral Pediatrics, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers/presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
| NAME | ROLE(S) | FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION |
| Brian Chicoine, MD | Medical Director, Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Robyn Filipink, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Katie Frank, PhD, OTR/L | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Catherine Frank, MBBS | Speaker | MapLight, Anavex Life Sciences (Both Contractor) | No |
| Amy Lyle, MSSW | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Cathy Means | Planner | No relevant relationships with ineligible companies to disclose | No |
| Lina Patel, PsyD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
| Emilie Perkins | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Moya Peterson, PhD, APRN, FNP-BC | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Eileen Quinn, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Maria Stanley, MD | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Mary Stephens, MD, MPH | Committee Member | No relevant relationships with ineligible companies to disclose | No |
Facebook
Twitter
LinkedIn
Forward
